Poster Presentations - Abstracts Texts

For the abstract text, please click on the orange button


PP01 99mTc-sestamibi SPECT/CT for the noninvasive diagnosis of benign renal oncocytomas and hybrid oncocytic/chromophobe tumors: combined data from prospective studies and real-world clinical experience
Michael A. Gorin1,2, Alexa R. Meyer1, Hiten D. Patel1, M. Som Javadi2, Phillip M. Pierorazio1, Steven P. Rowe1,2, Mohamad E. Allaf1
1The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore MD, USA
2The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore MD, USA



PP02 Cryoablation of small renal masses: our initial experience
Oscar Selvaggio1, Giovanni Silecchia1, Franco Lugnani2, Luigi Cormio1, Matteo Gravina3, Luca Macarini3, Giuseppe Carrieri1
1Department of Urology, University of Foggia, Italy
2Deparment of Urology, University of Ljubljana, Slovenia
3Department of Radiology, University of Foggia, Italy


PP03 New optical modality for prostate cancer visualization
Besarion Partsvania1, Tamaz Sulaberidze1, Alexandre Khuskivadze2, Ketevan Chubinidze1
1Georgian Technical University, Institute of Cybernetics, Tbilisi, Georgia
2Tbilisi State Medical University,Tbilisi, Georgia

PP04 Predictive significance of MRI-targeted biopsy for pathological and oncological outcomes after radical prostatectomy
Yoh Matsuoka1, Hiroshi Tanaka2, Tomo Kimura2, Yuma Waseda1, Sho Uehara1, Yosuke Yasuda1, Toshiki Kijima1, Soichiro Yoshida1, Minato Yokoyama1, Junichiro Ishioka1, Kazutaka Saito1, Kazunori Kihara1, Yasuhisa Fujii1
1Tokyo Medical and Dental University Graduate School, Tokyo, Japan
2Ochanomizu Surugadai Clinic, Tokyo, Japan


PP05 Prostate cancer detection rate of MRI/TRUS fusion vs. TRUS systematic biopsy. Impact of MRI setting and indications on biopsy outcome
Oscar Selvaggio1, Giovanni Silecchia1, Franco Lugnani2, Luigi Cormio1, Giuseppe Carrieri1
1Department of Urology, University of Foggia, Italy
2Department of Urology, University of Ljubljana, Slovenia

PP06 A bi-parametric MRI protocol may assist urologists to independently read prostate MRI images
David Margel, Stabholz Yariv, Lotan Paz, Roi Babaoff, Tamir Shlomit
Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel

PP07 Characterizing the learning curve of MRI-US fusion prostate biopsies
David Margel, Yaara Ber, Sivan Sela, Ira Belo, Tzlil Tabachnik, Ofer Benjaminov, Slomit Tamir, Jack Baniel
Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel

PP08 Predictors of prostate cancer detection in fusion biopsies
David Margel, Yaara Ber, Sivan Sela, Tzlil Tabachnik, Ira Belo, Ofer Benjaminov, Slomit Tamir, Jack Baniel
Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel

PP09 Prognostic impact of prostate imaging reporting and data system scores on oncological outcome
Sho Uehara1, Yoh Matsuoka1, Hiroshi Tanaka2, Yosuke Yasuda1, Toshiki Kijima1, Soichiro Yoshida1, Minato Yokoyama1, Junichiro Ishioka1, Kazutaka Saito1, Kazunori Kihara1, Yasuhisa Fujii1
1Department of Urology, Tokyo Medical and Dental University Graduate School, Tokyo, Japan
2Department of Radiology, Ochanomizu Surugadai Clinic, Tokyo, Japan


PP10 MR/US image-fusion targeted biopsy for diagnosis of clinically significant prostate cancer
Yasuhiro Yamada, Yuta Inoue, Fumiya Hongo, Koji Okihara, Osamu Ukimura
Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan

PP11 Prostate cancer in men who underwent surgery with negative staging mpMRI: an analysis of three Portuguese tertiary centers
Diogo Nunes-Carneiro1, José Pedro Nunes-Carneiro2, André Marques-Pinto1, Isaac Braga1, Vítor Cavadas1, Jorge Oliveira3, Estevão Lima4, Avelino Fraga1
1Centro Hospitalar do Porto, Portugal
2Escola de Medicina, Universidade do Minho, Braga, Portugal
3Instituto Portugues de Oncologia do Porto, Portugal
4Hospital de Braga, Braga, Portugal

PP12 Comparative outcomes after 4 different prostate biopsy techniques: a focus on standardized complication reporting
Cihan H. Demirel1, Muammer Altok1, John F. Ward1, Stephen E. McRae2, Mary F. Achim1, John W. Davis1
1Department of Urology, University of Texas MD Anderson Cancer Center, Houston TX, USA
2Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston TX, USA

PP13 What is so “equivocal” about PI-RADS 3 regions of interest?
Cihan H. Demirel1, Muammer Altok1, Hyunseon C. Kang2, Haesun Choi2, Joseph Andres1, Eugineo V. Familar1, John W. Davis1, John F. Ward1
1Department of Urology, University of Texas MD Anderson Cancer Center, Houston TX, USA
2Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston TX, USA

PP14 First prostate biopsy as MRI/Ultrasound Fusion guided: the biopsy challenge for US patients and payors
Muammer Altok1, Cihan H. Demirel1, Hyunseon C. Kang2, Haesun Choi2, David John1, Irene A. Inguillo1, John W. Davis1, John F. Ward1
1Department of Urology, University of Texas MD Anderson Cancer Center, Houston TX, USA
2Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston TX, USA

PP15 Correlation between template guided-transperineal biopsies and MRI diagnostic imaging
Stefano Regusci, Martina Martins Favre, Ildiko Szalay Quinodoz, Georges-Antoine De Boccard, Alexandre Caviezel, Stéphane Rohner, Yan Tuchschmid, Sao Tran, Charles-Henry Rochat
SIPC, Geneva, Switzerland

PP16 MRI-TRUS fusion prostate biopsies: learning curve experience with a multidisciplinary team approach
Cihan H. Demirel1, Muammer Altok1, Hyunseon C. Kang2, Haesun Choi2, Joseph Andres1, Eugineo V. Familar1, Xuemei Wang3, John W. Davis1, John F. Ward1
1Department of Urology, University of Texas MD Anderson Cancer Center, Houston TX, USA
2Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston TX, USA
3Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston TX, USA

PP17 Clinical utility of repeat prostate biopsy – A complimentary use of MRI/Fusion or transperineal template
Muammer Altok1, John F. Ward1, Cihan H. Demirel1, Haesun Choi2, Hyunseon C. Kang2, Mary F. Achim1, Eugineo V. Familar1, Joseph Andres1, John W. Davis1
1Department of Urology, University of Texas MD Anderson Cancer Center, Houston TX, USA
2Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston TX, USA

PP18 Value of shear wave elastography ultrasound for mpMRI guided ultrasound biopsy
Maaike Dotinga1, Jurgen Futterer2, Michiel Sedelaar2, Henkjan Huisman2
1TU Twente, Enschede, the Netherlands
2RadboudUMC, Nijmegen, the Netherlands

PP19 Prostate Health Index value to predict possibility of clinically significant lesion in multiparametric-Magnetic Resonance Imaging of prostate
Johnraj Kishore Raja Thinagaran, Himesh Gandhi, Chau Hung Lee, Yung Khan Tan
Tan Tock Seng Hospital, Singapore

PP20 Assessing the diagnostic accuracy of micro-ultrasound for the detection of clinically significant prostate cancer: results from a single-institutional preliminary experience
Giovanni Lughezzani, Davide Maffei, Massimo Lazzeri, Piergiuseppe Colombo, Giuliana Lista, Pasquale Cardone, Alberto Saita, Rodolfo Hurle, Paolo Casale, Nicoló Buffi, Giorgio Guazzoni
Humanitas Clinical and Research Center, Milan, Italy

PP21 Initial clinical experience of trimodal 18F-choline-PET/mpMRI/TRUS targeted prostate biopsies: a pilot study for a new concept
Jean-Louis Bonnal, Tanguy Blaire, Arnauld Delebarre, Alban Balliez, Pierre Gosset, Carherine Francois, Arnauld Marien, Kaled El Maadarani, Delphine Bessard, Aurelien Rock, Brigitte Mauroy
Université Nord de France GHICL, Lomme, France

PP22 Spatial analysis of prostate tumors using coregistered MRI, biopsy, and whole mount pathology
Alan M. Priester1, Warren Grundfest2, Leonard S. Marks1, Shyam Natarajan1,2
1Department of Urology, University of California, Los Angeles CA, USA
2Department of Bioengineering, University of California, Los Angeles CA, USA

PP23 Free-hand transperineal MRI/3D-TRUS fusion-guided prostate biopsy under local anesthesia
Eduard Baco1, Ljiljana Vlatkovic2, Erik Rud3
1Department of Urology, Oslo University Hospital, Oslo, Norway
2Department of Pathology, Oslo University Hospital, Oslo, Norway
3Department of Radiology, Oslo University Hospital, Oslo, Norway

PP24 Comparison between the diagnostic accuracy of micro-ultrasound versus multiparametric MRI in the detection of prostate cancer: preliminary results from a single-institutional ongoing prospective trial
Giovanni Lughezzani, Davide Maffei, Massimo Lazzeri, Paolo Casale, Pasquale Cardone, Giuliana Lista, Rodolfo Hurle, Alberto Saita, Piergiuseppe Colombo, Nicoló Buffi, Giorgio Guazzoni
Humanitas Clinical and Research Center, Milan, Italy

PP25 Imaging fusion guided prostate biopsy: the learning curve for urologists
Andre Luis de Castro Abreu, Masakatsu Oishi, Michael Lin-Brande, Akbar Ashrafi, Giovanni Cacciamani, Nima Nassiri, Toshitaka Shin, Matthew Winter, Osamu Ukimura, Manju Aron, Suzanne Palmer, Inderbir Gill
USC Institute of Urology, Los Angeles CA, USA

PP26 The effectiveness of bi-parametric MRI-ultrasound fusion prostate biopsy on detecting the clinically significant prostate cancer
Kyung Kgi Park, Jung Sik Huh
Jeju National University Hospital, Jeju, Korea Republic

PP27 MRI-US Fusion prostate biopsy: focus on detection rate and procedural complications in our first 130 cases
Bernardino de Concilio1, Elena Lievore1, Tommaso Silvestri2, Calogero Cicero3, Guglielmo Zeccolini1, Antonio Celia1
1Department of Urology, San Bassano Hospital, Bassano del Grappa, Italy
2Department of Urology, Cattinara Hospital, Trieste, Italy
3Department of Radiology, San Bassano Hospital, Bassano del Grappa, Italy

PP28 Initial experience performing in-office ultrasound-guided transperineal prostate biopsy under local anesthesia
Alexa R. Meyer, Gregory A. Joice, Zeyad R. Schwen, Alan W. Partin, Mohamad E. Allaf, Michael A. Gorin
The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore MD, USA

PP29 A simple modification for transperineal prostate fusion biopsy
Ahmet Gudeloglu1, Amirali Farahvash2, Sinan Sozen3, Cenk Yucel Bilen1
1Department of Urology, Faculty of Medicine, Hacettepe University, Ankara, Turkey
2Urology Clinic, Losante Hospital, Ankara, Turkey
3Department of Urology, Faculty of Medicine, Gazi University, Ankara, Turkey



PP30 Primary targeted Focal Therapy for prostate cancer: a pilot study in Japan
Yuta Inoue, So Ushijima, Koji Okihara, Motohiro Kanazawa, Yasuhiro Yamada, Atsuko Fujihara, Takumi Shiraishi, Fumiya Hongo, Osamu Ukimura
Kyoto Prefecture University of Medicine, Kyoto, Japan

PP31 Interim analysis of intervention trial evaluating focal therapy using high intensity focused ultrasound for the treatment of prostate cancer: safety, functional, psychological and oncological outcome 6 months after treatment
Ashkan Mortezavi, Johanna Krauter, Julian Sonderer, Alexander Gu, Julia Bruhin, Oliver Gross, Sarah Kedzia, Tullio Sulser, Daniel Eberli
Department of Urology, University Hospital Zurich, Switzerland

PP32 Cryosurgical hemiablation for low and intermediate risk of prostate cancer: 4 years of functional and initial oncological outcomes
Oscar Selvaggio1, Giovanni Silecchia1, Franco Lugnani2, Luigi Cormio1, Giuseppe Carrieri1
1Department of Urology, University of Foggia, Italy
2Department of Urology, University of Ljubljana, Slovenia

PP33 Transperineal MRI-US Fusion to aid conformal focal Ablation for intermediate risk anterior focal tumors
David Margel, Yaara Ber, Sivan Sela, Tzlil Tabachnik, Ira Belo, Ofer Benjaminov, Slomit Tamir, Jack Baniel
Rabin Medical Center, Beilinson Hospital, Petach Tikva, Israel

PP34 Initial experience using MRI-guided trans-perineal convective water vapor thermal ablation as a novel prostate cancer focal therapy in cadaveric prostates
Lance A. Mynderse, Barrett Howell, Krzysztof Gorny, Aiming Lu, David Woodrum
Mayo Clinic, Rochester MN, USA

PP35 The application of laser ablation for prostate cancer in the era of the financial crisis
Nikolaos Mertziotis, Diamandis Floratos, Andreas Konandreas, Christos Kyratsas
Iaso General Hospital, Athens, Greece

PP36 Pain during transrectal ultrasound guided prostatic biopsy: comparative study between peri-prostatic block with 1% lidocaine and intrarectal 2% licocaine gel – Farcosedan®
Diogo Nunes-Carneiro, André Marques-Pinto, Joao Cabral, Vitor Cavadas, Avelino Fraga
Centro Hospitalar do Porto, Porto, Portugal

PP37 Characterization of TRANBERG | Laser Applicator of diffuser type for Focal Laser Ablation in prostate cancer
Cristina Pantaleone1, Emily Emilsson1, Manuela Schwagmeier2, Verena Knappe2
1Clinical Laserthermia Systems AB, Medicon Village, Scheelevägen 2, 22381 Lund, Sweden
2Clinical Laserthermia Systems GmbH, Johann-Hittorf-Strasse 8, 12489 Berlin, Germany

PP38 Prostate targeted local therapy may be effective and safe for patients with newly diagnosed oligometastatic prostate cancer – A systematic review and meta-analysis
Zheng Xiaonan, Kun Jin, Lu Yang, Qiang Wei
Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu, China

PP39 A prospective randomized study of anti-inflammatory therapy for preventing the occurrence of prostate cancer and the transformation to castration-resistant prostate cancer: outcomes of two years’ follow-up
Xinyang Liao#, Siwei Bi#, Shi Qiu#, Lu Yang, Qiang Wei
Department of Urology, Institute of Urology, West China Hospital of Sichuan University, Chengdu, China
#contributed equally and share the first author place

PP40 Focal Cryotherapy for localized prostate cancer functional and oncological results
Renan Javier Otta-Oshiro, Fernando Lista-Mateos, José María García-Mediero, Carlos Núñez-Mora
MD Anderson Cancer Center, Madrid, Spain

PP41 Does African-American race impact oncologic outcomes follow primary cryotherapy for prostate cancer? A matched study from the cryo-on-line database (COLD) registry
Alireza Aminsharifi1, Matvey Tsivian1, Ariel Schulman1, Efrat Tsivian1, Jack Tay Kae2, Ahmed Elshafei3, Thomas J. Polascik1, Stephen Jones3
1Duke University Medical Center, Durham NC, USA
2SingHealth, Singapore General Hospital, Singapore
3Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland OH, USA


PP42 Salvage focal brachytherapy of the prostate after failed external beam radiotherapy: sparing the organs at risk result in acceptable toxicity profiles
Thelma Witteveen, Marcel Steggerda
The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands

PP43 Transrectally delivered, outpatient MRI-guided laser focal therapy of prostate cancer: seven-year interim results of NCT #02243033
John Feller1, Bernadette Greenwood1, Wesley Jones1, Robert Toth2
1Desert Medical Imaging, Indian Wells CA, USA
2Toth Technology LLC, New York NY, USA

PP44 Segmentary endoscopic prostatectomy as a new Focal Therapy approach to prostate cancer in men with symptomatic enlarged prostates
Bernardino Miñana López1, Ignacio Pascual Piédrola1, Antonio Romero Hoyuela2
1Clinica Universidad de Navarra, Madrid, Spain
2Hospital Morales Meseguer, Murcia, Spain

PP45 Hemi-ablation of the prostate by high-intensity focused ultrasound (HIFU) in patients with low- and intermediate-risk prostate cancer (PCa): a second follow-up analysis
Eduard Baco1, Erik Rud2, Ljiljana Vlatkovic3, Heidi B. Eggesbø2
1Department of Urology, Oslo University Hospital, Oslo, Norway
2Department of Radiology, Oslo University Hospital, Oslo, Norway
3Department of Pathology, Oslo University Hospital, Oslo, Norway

PP46 Hemi ablative low dose rate prostate brachytherapy for unilateral localised prostate cancer
Carla Perna, Santiago Uribe-Lewis, Jennifer Uribe, Adrian Franklin, Alex Horton, Robert Laing, Stephen Langley
St Luke's Cancer Centre, Guildford, United Kingdom

PP47 Focal cryoablation for low-, intermediate and high-risk prostate cancer
Masakatsu Oishi1, Akbar Ashrafi1, Osamu Ukimura1, Giovanni Cacciamani1, Toshitaka Shin1, Inderbir Gill1, Bahn Duke2, Andre Abreu1
1USC Institute of Urology, Los Angeles CA, USA
2PIOA - Prostate Institute of America, Ventura CA, USA

PP48 Prostate Radiofrequency Ablation Focal Treatment (proRAFT): results of a prospective development study for localized prostate cancer
Clement Orczyk1, Chris Brew-Graves1, Norman Williams1, Ingrid Potyka1, Navin Ramanchandran1, Alex Freeman1, Mark Emberton1, Hashim Uddin Ahmed2
1University College London, London, United Kingdom
2Imperial College London, London, United Kingdom

PP49 Focal Laser Ablation of prostate cancer: results in 121 patients with low to intermediate risk disease
Eric Walser, Anne Nance, Leslie Ynalvez, Shan Yong, Jacqueline Aoughsten, Eduardo Eyzaguirre, Stephen Williams
UTMB, Galveston TX, USA

PP50 Focal Laser Therapy for prostate cancer
Celi Varol1, Yassar Al Hakeem1, Orit Raz2
1Macquarie University Hospital, Sydney, Australia
2Assuta Ashdot Hospital, Ashdot, Israel

PP51 Transrectal ultrasound guided prostate biopsy antibiotic prophylaxis: standard vs. augmented antibiotic regimens, and the role for pre-biopsy rectal swab cultures
Mark Mann, Leonard Gomella, Edouard Trabulsi, Costas Lallas, J. Ryan Mark, W. Kevin Kelly, Robert D. Den, Christopher Caputo, Danielle Squadrito, Thomas Hardacker
TJU, Philadelphia PA, USA

PP52 Anterior gland image-guided focal cryoablation: proof-of-concept primary prostate cancer treatment in select men with localized anterior cancers detected by multi-parametric MRI
Christina Sze1, Efrat Tsivian2, Jack Tay Kae3, Ariel A. Schulman2, Leah G. Davis2, Rajan T. Gupta2, Thomas J. Polascik2
1Drexel University College of Medicine, Philadelphia PA, USA
2Duke University Medical Center, Durham NC, USA
3SingHealth, Singapore General Hospital, Singapore